Deutsch English Français

Contact

EP0862630

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0862630

EP0862630 - HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 18.04.2008 Database last updated on 15.06.2024
Most recent event Tooltip	06.03.2009	Lapse of the patent in a contracting state New state(s): FI	published on 08.04.2009 [2009/15]
Applicant(s)	For all designated states Biogen Idec Inc. 5200 Research Place San Diego, CA 92122 / US
	[2005/15]
Former [2004/43]	For all designated states Biogen Idec Inc. 3030 Callan Road San Diego, CA 92121 / US
Former [1998/37]	For all designated states IDEC PHARMACEUTICALS CORPORATION 11011 Torreyana Road San Diego, CA 92121-1104 / US
Inventor(s)	01 / BLACK, Amelia 2251 1/2 Oxford Avenue Cardiff, CA 92007 / US
	02 / HANNA, Nabil 14770 Avenida Insurgentes Rancho Santa Fe CA 92067 / US
	03 / PADLAN, Eduardo, A. 4006 Simms Drive Kensington, MD 20895 / US
	04 / NEWMAN, Roland, A. 4311 Robbins Street San Diego, CA 92122 / US
	[1999/08]
Former [1998/37]	01 / BLACK, Amelia 2251 1/2 Oxford Avenue Cardiff, CA 92007 / US
	02 / HANNA, Nabil 3255 Fortuna Ranch Road Olivenhian, CA 92024 / US
	03 / PADLAN, Eduardo, A. 4006 Simms Drive Kensington, MD 20895 / US
	04 / NEWMAN, Roland, A. 4311 Robbins Street San Diego, CA 92122 / US
Representative(s)	Adams, Harvey Vaughan John, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB
	[N/P]
Former [2007/43]	Adams, Harvey Vaughan John, et al Mathys & Squire 120 Holborn London EC1N 2SQ / GB
Former [2004/25]	Campbell, Patrick John Henry, et al J.A. Kemp & Co., 14 South Square, Gray's Inn London WC1R 5JJ / GB
Former [1998/37]	Daniels, Jeffrey Nicholas, et al Page White & Farrer 54 Doughty Street London WC1N 2LS / GB
Application number, filing date	96942732.7	07.11.1996
	[1998/37]
	WO1996US17875
Priority number, date	US19950554840	07.11.1995 Original published format: US 554840
	[1998/37]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO9717446
	Date:	15.05.1997
	Language:	EN
	[1997/21]
	Type:	A2 Application without search report
	No.:	EP0862630
	Date:	09.09.1998
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.05.1997 takes the place of the publication of the European patent application.
	[1998/37]
	Type:	B1 Patent specification
	No.:	EP0862630
	Date:	13.06.2007
	Language:	EN
	[2007/24]
Search report(s)	International search report - published on:	EP	25.09.1997
Classification	IPC:	C12N15/13, C07K16/46, C07K16/28, A61K39/395	[1998/37]
	CPC data not yet available
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1998/37]
Extension states	AL	01.06.1998
	LT	01.06.1998
	LV	01.06.1998
	RO	01.06.1998
	SI	01.06.1998
Title	German:	HUMANISIERTE ANTIKÖRPER GEGEN HUMANES GP39, ZUSAMMENSETZUNGEN DIE DIESE ENTHALTEN UND DEREN THERAPEUTISCHE VERWENDUNGEN	[1998/37]
	English:	HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF	[1998/37]
	French:	ANTICORPS HUMANISES DIRIGES CONTRE LA gp39 D'ORIGINE HUMAINE, COMPOSITIONS CONTENANT CES ANTICORPS ET LEUR UTILISATION THERAPEUTIQUE	[1998/37]
Entry into regional phase	01.06.1998	National basic fee paid
	01.06.1998	Designation fee(s) paid
	01.06.1998	Examination fee paid
Examination procedure	06.06.1997	Request for preliminary examination filed International Preliminary Examining Authority: EP
	01.06.1998	Examination requested [1998/37]
	12.08.2003	Despatch of a communication from the examining division (Time limit: M10)
	18.06.2004	Reply to a communication from the examining division
	10.10.2005	Despatch of a communication from the examining division (Time limit: M04)
	31.01.2006	Reply to a communication from the examining division
	22.02.2006	Despatch of a communication from the examining division (Time limit: M06)
	04.09.2006	Reply to a communication from the examining division
	06.11.2006	Communication of intention to grant the patent
	14.03.2007	Fee for grant paid
	14.03.2007	Fee for publishing/printing paid
Opposition(s)	14.03.2008	No opposition filed within time limit [2008/21]
Fees paid	Renewal fee
	10.11.1998	Renewal fee patent year 03
	12.11.1999	Renewal fee patent year 04
	13.11.2000	Renewal fee patent year 05
	14.11.2001	Renewal fee patent year 06
	13.11.2002	Renewal fee patent year 07
	12.11.2003	Renewal fee patent year 08
	22.11.2004	Renewal fee patent year 09
	29.11.2005	Renewal fee patent year 10
	27.11.2006	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	13.06.2007
	BE	13.06.2007
	CH	13.06.2007
	DK	13.06.2007
	FI	13.06.2007
	LI	13.06.2007
	NL	13.06.2007
	SE	13.09.2007
	GR	14.09.2007
	ES	24.09.2007
	PT	13.11.2007
	[2009/15]
Former [2008/23]	AT	13.06.2007
	BE	13.06.2007
	CH	13.06.2007
	DK	13.06.2007
	LI	13.06.2007
	NL	13.06.2007
	SE	13.09.2007
	GR	14.09.2007
	ES	24.09.2007
	PT	13.11.2007
Former [2008/21]	AT	13.06.2007
	BE	13.06.2007
	CH	13.06.2007
	LI	13.06.2007
	NL	13.06.2007
	SE	13.09.2007
	GR	14.09.2007
	ES	24.09.2007
	PT	13.11.2007
Former [2008/12]	AT	13.06.2007
	BE	13.06.2007
	CH	13.06.2007
	LI	13.06.2007
	NL	13.06.2007
	SE	13.09.2007
	ES	24.09.2007
	PT	13.11.2007
Former [2008/08]	AT	13.06.2007
	BE	13.06.2007
	CH	13.06.2007
	LI	13.06.2007
	SE	13.09.2007
	ES	24.09.2007
Former [2008/07]	AT	13.06.2007
	BE	13.06.2007
	CH	13.06.2007
	LI	13.06.2007
	SE	13.09.2007
Cited in	International search	[A]EP0519596 (MERCK & CO INC [US], et al) [A] 1-5,7-14 * example . * * claim - *;
		[A]WO9506666 (DARTMOUTH COLLEGE [US], et al) [A] 25-31 * example - * * claim - *;
		[X]WO9528957 (DARTMOUTH COLLEGE [US], et al) [X] 1-3,14,17,25,28,29 * example - * * claim - *;
		[PX]WO9623071 (BRISTOL MYERS SQUIBB CO [US], et al) [PX] 1-31 * example - ** claim - *;
		[DA] - F. DURIE ET AL., "Prevention of colagen-induced arthritis with an antibody to gp39, the ligand for CD40.", SCIENCE, WASHINGTON, DC, USA, (19930903), vol. 261, no. 5126, pages 1328 - 1330, XP002035702 [DA] 25-27,30 * the whole document * DOI: http://dx.doi.org/10.1126/science.7689748

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p